Screener
Amylyx Pharmaceuticals, Inc. AMLX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.0001 par value; 300,000,000 shares authorized; 111,368,283 and 109,884,502 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 11 | 11 |
| Additional paid-in capital | 1,075,271 | 1,056,271 |
| Accumulated deficit | (836,134) | (751,427) |
| Accumulated other comprehensive income | 19 | 404 |
| Total stockholders’ equity | 239,167 | 305,259 |
Item 1. Financial Statements.
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s common stock?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported common stock of $11K in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s common stock increased by 22.2% year-over-year, from $9K to $11K.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s common stock?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s common stock has grown at a 82.1% compound annual growth rate (CAGR), from $1K to $11K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Amylyx Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude